Related Experiment Video
Updated: Apr 28, 2026

09:33
Neuronavigated Focalized Transcranial Direct Current Stimulation Administered During Functional Magnetic Resonance Imaging
Published on: November 15, 2024
2.1K
A novel phase-difference transcranial alternating current stimulation system enables precise dual-site
Ruiren Wu1,2, Ying Feng2,3, Jiali Wu4
1School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Frontiers in Neuroscience
|April 27, 2026
Summary
We developed a novel phase-difference transcranial alternating current stimulation (tACS) system for precise brain network modulation. This PD-stim technology offers stable, accurate dual-channel phase control, overcoming limitations of current tACS devices.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Neurotechnology
Background:
- Precise modulation of large-scale brain networks requires advanced neuromodulation with frequency-locked stimulation and stable inter-regional phase control.
- Conventional transcranial alternating current stimulation (tACS) systems often lack robust dual-channel phase regulation and validation under realistic biological impedance conditions.
Purpose of the Study:
- To present and validate a novel phase-difference tACS system (PD-stim) for programmable, high-precision phase offsets between stimulation targets.
- To assess the biological impedance stability, waveform fidelity, amplitude stability, and phase-delivery accuracy of the PD-stim system.
Main Methods:
- Engineering and in vivo validation of the PD-stim system.
- Measurement of biological impedance in rat medial prefrontal cortex and hippocampus during stimulation.
- Benchmark comparisons with a clinically approved tACS device using standardized resistive loads and in vivo conditions.
- Simultaneous dual-channel oscilloscope recordings to assess waveform fidelity and phase accuracy across theta, beta, and gamma frequency bands.
Main Results:
- Stable, frequency-dependent biological impedance profiles were observed in rat brain regions during stimulation.
- PD-stim demonstrated comparable waveform fidelity and amplitude stability to a clinical tACS device under both resistive and in vivo conditions.
- PD-stim consistently achieved high phase-delivery accuracy with stable sinusoidal waveforms across multiple frequency bands (theta, beta, gamma) under diverse conditions.
Conclusions:
- The PD-stim system is a precise, stable, and biologically robust dual-site neuromodulation platform.
- This technology overcomes key technical limitations of existing tACS systems for phase-specific brain network modulation.
- The validated engineering framework supports future investigations into the mechanisms of phase-specific neuromodulation in distributed brain networks.

